- Senior Investigator, Laboratory of Human Carcinogenesis
Dr. Stefan Ambs earned a Master's degree in Biochemistry from the University of Tuebingen (1988) and a Master of Public Health degree (Epidemiology) from the Johns Hopkins Bloomberg School of Public Health (2005). He completed his Ph.D. thesis (1992) at the Institute of Toxicology, University of Wuerzburg, Germany, and was trained as a Postdoctoral Fellow at the Laboratory of Human Carcinogenesis (1992-1997), National Cancer Institute, Bethesda, Maryland. He continued his research at a biotechnology company in California and at the Aventis Genomics Center in Cambridge, Massachusetts. Dr. Ambs joined the NCI as a tenure-track investigator in November of 2001. He became a tenured Senior Investigator in 2010.
- (2020). Genome-Wide Analysis of the FOXA1 Transcriptional Network Identifies Novel Protein-Coding and Long Noncoding RNA Targets in Colorectal Cancer Cells. MOLECULAR AND CELLULAR BIOLOGY. 40(21),
- (2020). Pyrvinium Pamoate Induces Death of Triple-Negative Breast Cancer Stem-Like Cells and Reduces Metastases through Effects on Lipid Anabolism. CANCER RESEARCH. 80(19), 4087-4102.
- (2020). A Viral Exposure Signature Defines Early Onset of Hepatocellular Carcinoma. CELL. 182(2), 317-+.
- (2020). miR-484 is associated with disease recurrence and promotes migration in prostate cancer. BIOSCIENCE REPORTS. 40,